Although the FDA is not the only health authority that identifies these issues in inspections and enforcement actions, their transparency ensures the data is readily available. See what the FDA is doing here.
We’re back from DIA 2019 held in San Diego.While the conference consumed almost the entire convention center, the number of attendees walking the exhibit area was limited. This may have been a testament to the quality of the sessions as overall attendance was on par...
We’re back! CTIS was abuzz about Digital Biomarkers and their applications in clinical trials. Several definitions floated around, but we liked the simplest one — “user-generated physiological indications captured by a device.” Many of the speakers discussed...
Click Here to Learn More About Adaptive Clinical Systems Learn More We’re back! Medrio EXPLORE 2019 was well attended with twice as many participants as last year. As first-time sponsors, we found the attendees to be very engaged and committed to learning how...
Click Here to Learn More About Adaptive Clinical Systems Learn More We just got back from SCOPE 2019 and happy to report it was bigger than previous years with over 1900 attendees. This demonstrates a trend that shows the level of interest in clinical...
